Disclosure: this article contains affiliate links. If you buy through them, we may earn a commission at no extra cost to you. Prices were checked in September 2026.
Willow GLP-1 Review: The Quick Answer
Willow (startwillow.com) sells compounded semaglutide and tirzepatide, not FDA-approved Wegovy, Ozempic, Zepbound, or Mounjaro. Plans run $299 a month for semaglutide up to $524 for the highest tirzepatide dose, all-inclusive of the doctor visit and shipping. It excludes anyone with diabetes and is not the fit if you want an FDA-reviewed drug. See current Willow pricing before deciding.
What Willow Actually Sells: Compounded, Not Brand-Name
Willow’s own product pages sell three things: compounded semaglutide injection (branded on the site as “Semaglutide Plus,” mixed with vitamin B12), compounded semaglutide sublingual tablets, and compounded tirzepatide. None of the three is Wegovy, Ozempic, Zepbound, or Mounjaro. Willow says so itself: its safety disclosures state that its compounded products “are not approved by the FDA” and have not gone through FDA review for safety, effectiveness, or quality. The drugs are mixed to order at “state-licensed compounding pharmacies,” under state board oversight and USP compounding standards, not the FDA’s approval pathway. Willow does not publish the name of the pharmacy filling its orders.
This is the fact most “Willow review” pages bury or skip. Compounded does not mean fake, it means a pharmacy mixes the same active ingredient into its own formulation, at its own facility, without the FDA ever testing that specific batch, dose, or delivery method. The active ingredient can be legitimate. The manufacturing and oversight are a different animal from a Novo Nordisk or Eli Lilly production line.
Who Should NOT Use Willow, or Any GLP-1 for Weight Loss
Read this section before the pricing. Willow itself will not enroll certain people, and there are additional groups who should stay away from semaglutide and tirzepatide regardless of which company sells it.
- People with diabetes. Willow’s own FAQ states plainly that it does not treat individuals with diabetes, though pre-diabetes and hypertension are accepted. This is an off-label weight-loss-only model, not a diabetes-management program.
- Anyone pregnant or breastfeeding. Willow excludes this group outright, matching the labeling on every FDA-approved GLP-1.
- Anyone with a personal or family history of medullary thyroid carcinoma (MTC), or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). This is a hard contraindication on the FDA-approved labels for both Wegovy and Zepbound: in animal studies, semaglutide and tirzepatide caused thyroid C-cell tumors, and while it is unknown whether this happens in humans, the contraindication stands for the drug class, not just the brand name.
- Anyone with a history of pancreatitis or gallbladder disease. Acute pancreatitis and gallbladder problems, including gallstones, are documented risks on the FDA-approved labels for this drug class.
- Anyone who specifically wants a drug the FDA has reviewed for safety and effectiveness. If that matters to you, compounded is the wrong category, full stop, regardless of price. Willow does not offer FDA-approved brand-name product as an option.
Willow’s eligibility page does not publish a specific BMI cutoff. It only states you must be 18 or older and free of certain unnamed medical conditions, which the intake questionnaire screens for. If a BMI threshold matters to your decision, ask during the intake call rather than assuming a number.
Willow’s Pricing, Every Tier
Willow prices by product and, for tirzepatide, by dose. Every tier is billed monthly and quoted as an all-in price that includes the medical evaluation, ongoing physician messaging, and shipping.
| Product | Monthly price | What’s included |
|---|---|---|
| Compounded semaglutide injection (Semaglutide Plus, with B12) | $299/mo | Prescription, medical evaluation, unlimited physician messaging, free shipping |
| Compounded semaglutide sublingual tablets | $299/mo | Same as above |
| Compounded tirzepatide, standard doses | $399/mo | Same as above |
| Compounded tirzepatide, 10mg-12.5mg | $499/mo | Same as above |
| Compounded tirzepatide, 15mg | $524/mo | Same as above |
Willow’s plan auto-renews every month, and you can cancel anytime by messaging the Patient Care Team. If you cancel before your order ships to the pharmacy, Willow says you get a full refund within 5 to 10 business days. Once it ships, it does not. HSA and FSA cards are accepted; Willow does not bill insurance, and none of the compounded products are insurance-eligible the way an FDA-approved prescription can be. Confirm your exact dose pricing on Willow’s site before you submit an intake, since compounding pricing shifts faster than brand pricing does.
Willow vs. Brand-Name GLP-1s: The Comparison Nobody Runs
Here is the math most “Willow review” articles skip: how Willow’s compounded price stacks up against the real, FDA-approved drug bought straight from the manufacturer, and against another compounded competitor. Prices below are cash prices, checked at each company’s own site in September 2026.
| Provider | Drug type | Cash price per month | Insurance |
|---|---|---|---|
| Willow | Compounded semaglutide or tirzepatide | $299 to $524, all-inclusive | Not accepted; HSA/FSA eligible |
| Henry Meds | Compounded semaglutide injection | $297/mo, plus a separate $30 consultation fee | Not accepted |
| Mochi Health | Compounded semaglutide or tirzepatide | Starting at $60 to $90/mo drug cost, plus $79/mo membership after the first month | Not verified |
| LillyDirect (Zepbound, real tirzepatide) | FDA-approved, straight from Eli Lilly | $299 (2.5mg) to $449 (7.5-15mg), no membership fee, if you refill within 45 days | Some plans accepted |
| NovoCare Pharmacy (Wegovy, real semaglutide) | FDA-approved, straight from Novo Nordisk | $149 (pill) to $399 (highest-dose pen), no membership fee | Not insurance-billed; FSA/HSA eligible |
| Hims & Hers | FDA-approved brand only (dropped compounded GLP-1s) | $149 to $1,899 drug cost, plus $149/mo membership | Not required, not accepted |
The number that should stop you: at the 15mg dose, Willow’s compounded tirzepatide runs $524 a month. The real, FDA-approved Zepbound, bought directly from Eli Lilly, runs $449 at that same dose if you refill on time, meaning you can pay more for the unapproved version of the same drug. On the semaglutide side, Willow’s flat $299 sits inside the same range as NovoCare’s real Wegovy pill ($149 to $299) and pen ($199 to $399), not meaningfully below it. The old case for compounded, that it is dramatically cheaper than the real thing, has mostly evaporated for tirzepatide and is weak for semaglutide once you compare against manufacturer-direct pricing rather than telehealth brand markups.
Side Effects and the Warnings a Compounded Label Skips
Willow’s own site lists the common side effects patients report: nausea, vomiting, diarrhea, constipation, abdominal pain, decreased appetite, and indigestion, consistent with every GLP-1 or GIP medication on the market, brand or compounded.
What a compounded product does not come with is an FDA-reviewed label. The FDA-approved labels for Wegovy and Zepbound, the closest brand-name equivalents to what Willow sells, carry a boxed contraindication against use in anyone with a personal or family history of medullary thyroid carcinoma or MEN 2, based on thyroid C-cell tumors observed in animal studies. Those labels also document acute pancreatitis, including rare fatal cases, and gallbladder disease as risks tied to the drug class. Buying compounded means taking on the same underlying pharmacology risk without the FDA-mandated labeling that would normally spell it out to you and your pharmacist.
There is also a mechanical risk specific to compounded GLP-1s. The FDA issued an alert after providers and patients confused dosing units on syringes, in one documented case intending 0.25 milligrams and instead administering 25 units, five to twenty times the intended amount. The FDA has also told patients to discard compounded semaglutide vials 28 days after first use, even when a compounder’s own instructions claim a longer shelf life. Willow ships some products as a multi-week supply, so ask directly how your shipment is dosed and how long it is meant to last before drawing up a single unit.
What Happens When You Stop Taking It
Semaglutide and tirzepatide, brand or compounded, are not a cure, they suppress appetite while you take them. The extension of the STEP 1 clinical trial followed patients for a year after stopping semaglutide 2.4mg plus lifestyle coaching: those participants had lost 17.3% of body weight by week 68, then regained about two-thirds of that loss by week 120, ending with a net loss of only 5.6%. Cardiometabolic markers that improved on the drug drifted back toward baseline too. Willow’s cancel-anytime structure means you are free to stop, but the biology does not care about your billing cycle. Budget the medication as a long-term line item, not a short course.
The Regulatory Squeeze on Compounded GLP-1s, and Where Willow Sits In It
Compounded semaglutide and tirzepatide exist as a legal category mainly because both drugs sat on the FDA’s official shortage list for years. That shortage is over: the FDA declared tirzepatide resolved on December 19, 2024, and semaglutide resolved on February 21, 2025, which triggered wind-down deadlines for compounders through spring 2025. Compounders can still operate under a narrower exception: the FDA’s April 2026 “personalized dosing” policy allows it only when a prescriber documents an individual patient needs something meaningfully different from the commercial product, not the same drug with an extra ingredient added. Willow’s injectable, semaglutide mixed with vitamin B12, sits close to the exact formulation this rule was written to scrutinize.
Willow has already been tested on this exact question, and lost on the merits, if not in court. In December 2025, the BBB National Programs’ National Advertising Division, acting on a challenge from Novo Nordisk, reviewed Willow’s marketing for its “Semaglutide Tablets” and “Semaglutide Plus” products and found Willow had not substantiated its weight-loss claims, which leaned on clinical trial results generated for FDA-approved semaglutide, a different formulation than what Willow ships. Willow declined to change the marketing, so NAD referred the matter to state and federal regulators. Separately, Eli Lilly sued Willow Health Services in April 2025, one of only four telehealth companies it targeted (with Mochi Health, Fella Health, and Henry Meds), alleging Willow marketed “cosmetic weight loss” tirzepatide as safe and effective and falsely called it “personalized.” A judge dismissed Lilly’s case against Willow in February 2026 on procedural grounds only, a physician’s prescription, not Willow’s advertising, causes any lost brand-name sales, not a finding that Willow’s claims were accurate.
None of this means Willow operates illegally today. It means the legal room compounded GLP-1s rely on is narrowing: a proposed April 2026 FDA rule would remove semaglutide, tirzepatide, and liraglutide from the ingredients list compounders may use at all, and Willow specifically has already drawn a formal advertising-substantiation finding. Treat any “clinically proven” language on a compounded product’s marketing, Willow’s included, with real skepticism.
How Willow Sign-Up Actually Works
The process is short by design. Here is what actually happens, step by step, based on Willow’s own site.
- Start the intake questionnaire on Willow’s site, answering questions about health history, current medications, and weight-loss goals. There is no upfront charge to submit it.
- A licensed physician reviews your answers. Willow says its network uses licensed physicians, not nurse practitioners; ask which state your assigned doctor is licensed in during your evaluation if that matters to you.
- Get same-day approval or a decline. If approved, your plan and dose are set and your card is charged the monthly price for the product you were matched to.
- Your prescription goes to Willow’s partner compounding pharmacy, which Willow does not name publicly. Once the order ships, cancellation no longer qualifies for a refund, so this is your last real off-ramp.
- Medication arrives by free shipping, typically within about 2 business days once dispatched per Willow’s own claims, with 24/7 messaging access to the care team afterward.
Willow vs. Ro vs. Henry Meds: Which One Actually Fits You
If your priority is an FDA-approved drug, Willow is not the right shortlist entry. Check our breakdown of the best GLP-1 telehealth providers for brand-only options like Ro and Hims, both of which have already dropped compounded products for Wegovy, Zepbound, Ozempic, and Mounjaro.
If compounded is acceptable to you and you are weighing Willow against another compounded provider, Willow’s all-inclusive flat pricing ($299 to $524, doctor visit and shipping bundled in) is simpler to budget than Henry Meds, where a $297/mo semaglutide plan sits on top of a separate $30 consultation fee. Our Ro vs. Henry Meds comparison walks through that fee structure and complaint history in detail. For how dosing and delivery method affect results across the category, see our guide to the best injections for weight loss.
Frequently Asked Questions
Is Willow a legitimate company?
Willow is a real, operating telehealth company that connects patients with licensed physicians and compounding pharmacies; it is not a scam in the sense of taking money and delivering nothing. But “legitimate business” and “FDA-approved medication” are two separate claims. Willow sells compounded drugs that have not been through FDA review, and its marketing has already drawn a formal, unresolved advertising-substantiation finding from the BBB National Programs’ National Advertising Division in December 2025.
Is Willow’s compounded semaglutide the same as Ozempic or Wegovy?
It uses the same active ingredient in most cases, but it is not the same product. Compounded semaglutide is mixed at a compounding pharmacy in its own formulation, sometimes combined with other ingredients like B12, and delivered as an injection or sublingual tablet rather than the specific pen device the FDA reviewed and approved for Wegovy. The FDA has not evaluated Willow’s specific formulations for safety, effectiveness, or quality.
Does insurance cover Willow?
No. Willow does not bill insurance for its compounded products. It accepts HSA and FSA cards, and the entire model is cash-pay.
Can I cancel my Willow plan anytime?
Yes, by messaging the Patient Care Team, and Willow’s plan auto-renews monthly rather than locking you into a long-term contract. You only qualify for a refund if you cancel before your order has already shipped to the pharmacy; after that, the charge is final.
Who should avoid GLP-1 medications like this altogether?
Anyone with a personal or family history of medullary thyroid carcinoma or MEN 2, anyone with a history of pancreatitis or gallbladder disease, anyone pregnant or breastfeeding, and, specifically for Willow, anyone with diabetes, since Willow does not treat that population. Talk to your own doctor about your full medical history before starting any GLP-1, compounded or brand-name.
Will I regain the weight if I stop?
Most people do, at least partially. Clinical follow-up data on semaglutide shows roughly two-thirds of lost weight returning within a year of stopping the drug. Treat it as a long-term commitment, not a short course, when you’re budgeting the monthly cost.
The Bottom Line
Willow is a real telehealth business selling compounded, not FDA-approved, semaglutide and tirzepatide, at prices that, once you actually compare them to manufacturer-direct pricing for the real drugs, are not the bargain the compounded pitch usually promises, especially at higher tirzepatide doses. Its own advertising for those exact products has already been challenged and found unsubstantiated by an independent industry review board that referred the matter to regulators. That does not make Willow uniquely bad among compounded GLP-1 sellers, most of the same criticisms apply across the category, but it does mean you should go in with your eyes open about what you are buying and why. If you still want to check your eligibility and current pricing with Willow, do it with the compounded-versus-brand math from this article in hand, and bring your full medical history to the intake so a licensed physician, not a questionnaire, makes the actual call.
This article is for informational purposes only and is not medical advice. It does not diagnose, treat, or replace a consultation with a licensed physician. Talk to your own doctor about whether a GLP-1 medication, compounded or FDA-approved, is appropriate for your health history before starting one.
